Q32 Bio (QTTB) Capital Expenditures (2017 - 2026)
Q32 Bio's quarterly Capital Expenditures came in at $175000.0 in Q1 2026, down 29.15% year-on-year from $247000.0 in Q1 2025, and down 81.79% quarter-over-quarter from $961000.0 in Q4 2025.
Q32 Bio has reported Capital Expenditures for 10 years, with the latest figure at $175000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures fell 29.15% year-over-year to $175000.0; the trailing twelve-month figure through Mar 2026 stood at $889000.0 (up 329.47% YoY), and the FY2025 full-year result was $961000.0, up 1181.33% from the prior year.
- Capital Expenditures for Q1 2026 stood at $175000.0, down from $961000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $1.2 million in Q2 2022, with the low at -$527000.0 in Q4 2024.
- Average Capital Expenditures over 5 years is $166733.3, with a median of $115000.0 recorded in 2024.
- Year-over-year, Capital Expenditures slumped 3283.33% in 2023 and soared 2200.0% in 2024.
- Tracing QTTB's Capital Expenditures over 5 years: stood at $9000.0 in 2022, then plunged by 2222.22% to -$191000.0 in 2023, then tumbled by 175.92% to -$527000.0 in 2024, then surged by 282.35% to $961000.0 in 2025, then slumped by 81.79% to $175000.0 in 2026.
- The last three Capital Expenditures figures came in at $175000.0 (Q1 2026), $961000.0 (Q4 2025), and -$247000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | 175,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 175,000.00 |
| Mar 31, 2026 | 175,000.00 |
| Dec 31, 2025 | 961,000.00 |
| Dec 31, 2025 | 961,000.00 |
| Jun 30, 2025 | -247,000.00 |
| Jun 30, 2025 | -247,000.00 |
| Mar 31, 2025 | 247,000.00 |
| Mar 31, 2025 | 247,000.00 |
| Dec 31, 2024 | -527,000.00 |
| Dec 31, 2024 | -527,000.00 |
| Sep 30, 2024 | 264,000.00 |
| Sep 30, 2024 | 264,000.00 |
| Jun 30, 2024 | 223,000.00 |
| Jun 30, 2024 | 223,000.00 |
| Mar 31, 2024 | 115,000.00 |
| Mar 31, 2024 | 115,000.00 |
| Sep 30, 2023 | -191,000.00 |
| Sep 30, 2023 | -191,000.00 |
| Jun 30, 2023 | 191,000.00 |
| Jun 30, 2023 | 191,000.00 |
| Mar 31, 2023 | 5,000.00 |
| Mar 31, 2023 | 5,000.00 |
| Dec 31, 2022 | 9,000.00 |
| Dec 31, 2022 | 9,000.00 |
| Sep 30, 2022 | 6,000.00 |
| Sep 30, 2022 | 6,000.00 |
| Jun 30, 2022 | 1.21 Mn |
| Jun 30, 2022 | 1.21 Mn |
| Mar 31, 2022 | 59,000.00 |
| Mar 31, 2022 | 59,000.00 |
| Dec 31, 2021 | 207,000.00 |
| Dec 31, 2021 | 207,000.00 |
| Sep 30, 2021 | -60,000.00 |
| Sep 30, 2021 | -60,000.00 |
| Jun 30, 2021 | -723,000.00 |
| Jun 30, 2021 | -723,000.00 |
| Mar 31, 2021 | 817,000.00 |
| Mar 31, 2021 | 817,000.00 |
| Dec 31, 2020 | -2.67 Mn |
| Dec 31, 2020 | -2.67 Mn |
| Sep 30, 2020 | 157,000.00 |
| Sep 30, 2020 | 157,000.00 |
| Jun 30, 2020 | 2.22 Mn |
| Jun 30, 2020 | 2.22 Mn |
| Mar 31, 2020 | 405,000.00 |
| Mar 31, 2020 | 405,000.00 |
| Dec 31, 2019 | -227,000.00 |
| Dec 31, 2019 | -227,000.00 |
| Sep 30, 2019 | -15.70 Mn |
| Sep 30, 2019 | -15.70 Mn |
| Jun 30, 2019 | 11.11 Mn |
| Jun 30, 2019 | 11.11 Mn |
| Mar 31, 2019 | 5.27 Mn |
| Mar 31, 2019 | 5.27 Mn |
| Dec 31, 2018 | 15.93 Mn |
| Dec 31, 2018 | 15.93 Mn |
| Sep 30, 2018 | 4.83 Mn |
| Sep 30, 2018 | 4.83 Mn |
| Jun 30, 2018 | 4.16 Mn |
| Jun 30, 2018 | 4.16 Mn |
| Mar 31, 2018 | 27,000.00 |
| Mar 31, 2018 | 27,000.00 |
| Dec 31, 2017 | 336,735.00 |
| Dec 31, 2017 | 336,735.00 |
| Sep 30, 2017 | 1.47 Mn |
| Sep 30, 2017 | 1.47 Mn |
| Jun 30, 2017 | -701,698.00 |
| Jun 30, 2017 | -701,698.00 |
| Mar 31, 2017 | 848,433.00 |
| Mar 31, 2017 | 848,433.00 |